Ovarian Cancer Trial May Help 30% More Patients

October 16, 2019

Ovarian Cancer Trial May Help 30% More Patients

Cancer patients at the Sylvester Comprehensive Cancer Center that participated in a clinical trial for ovarian cancer have impacted the way the disease is understood. The study proved that an anti-cancer drug called veliparib, which targets the way DNA repairs itself, might help up to 30% more patients. Yourway increases access to life-saving medicine by being on the forefront of the clinical trial supply chain.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

SCOPE Supply Chain & Logistics Leadership Summit

February 2-5, 2026
Orlando, Florida

Schedule a Meeting

Global Clinical Supplies Group Asia Pacific Conference

March 10-12, 2026
Conrad Seoul Hotel, South Korea

Schedule a Meeting

Media

Articles

When is it time to switch to a biopharma-specialized courier?

Open chat

Hello! How can I help you?